Press releases

For the first time in Europe, Tübingen physicians make use of an RNA therapy specifically tailored to one patient

Read more

A pioneering collaborative project between a Baden-Württemberg research team and patient association receive two million U.S. dollars

Read more

Protein plaques in the brain are the cause of Alzheimer's disease and the starting point for possible therapies. At later stages, however, the disease...

Read more

Researchers from Tübingen discover link between the protein medin and Alzheimer's disease

Read more

A Tübingen research project receives 1.6 million US dollars from the Chan Zuckerberg Initiative

Read more

Press release in German only

Read more

We are very bad at recalling objects at our gaze direction from short-term memory - even though this is the area we see most sharply, report brain...

Read more

A new multicenter study led by Prof. Ulf Ziemann receives funding of 1.6 million euros. Read our press release (in German only)

Read more

They could provide information about inflammatory processes in diseases such as Alzheimer's or Parkinson's as biomarkers

Read more

Press release in German only

Read more
Press contact
Press contactDirector of Communications
Silke DutzPhone 07071 29 88802silke.dutz@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research
Director of Communications

Otfried-Müller-Str. 27
72076 Tübingen